Ignite Creation Date:
2024-05-05 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00428948
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2007-01-26
Brief Title:
Tolvaptan Phase 3 Efficacy and Safety Study in Autosomal Dominant Polycystic Kidney Disease ADPKD
Sponsor:
Otsuka Pharmaceutical Development Commercialization Inc
Organization:
Otsuka Pharmaceutical Development Commercialization Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-01
Start Date Type:
None
Primary Completion Date:
2012-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-01
Completion Date Type:
ACTUAL
First Submit Date:
2007-01-26
First Submit QC Date:
January 29 2007
Study First Post Date:
2007-01-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2017-07-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2013-02-01
Disp First Submit QC Date:
February 1 2013
Disp First Post Date:
2013-02-04
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2017-05-30
Last Update Post Date:
2017-07-02
Last Update Post Date Type:
ACTUAL